One of the first lessons beginning investors learn is the value of diversification in preventing big losses. But in order to reap the largest gains when they make the right call, aggressive investors often use concentrated portfolios to tap into trends they see as potentially providing explosive growth opportunities.
Unfortunately, those big bets don't always work out. Hedge fund giant John Paulson has learned that lesson well this year with his gold-oriented fund, which has lost 65% of its value so far in 2013. Let's take a look at what happened to Paulson and what it can teach you about taking concentrated positions in your own portfolio, especially in volatile investments like gold.
Image source: Wikimedia Commons.
The Paulson story
John Paulson made his name by making investments that gained in value when subprime mortgages crashed in the lead-up to the financial crisis. Even now, Paulson is keeping a close eye on housing, but lately, he's been playing the space from the other direction with bullish bets on mortgage insurance companies MGIC Investment (NYSE: MTG ) and Radian Group (NYSE: RDN ) . His argument is basically that as long as the housing market has hit bottom, prospects for further losses are minimal, allowing mortgage insurers to make up for past losses.
Best Healthcare Equipment Stocks To Buy Right Now: Astec Industries Inc.(ASTE)
Astec Industries, Inc. engages in the design, engineering, manufacture, and marketing of equipment and components for road building, utility, and related construction activities worldwide. The company?s Asphalt Group segment offers hot-mix asphalt plants, concrete mixing plants, and related components; heating and heat transfer processing equipment; and thermal fluid storage tanks for asphalt paving and other non-related industries. Its Aggregate and Mining Group segment provides jaw, cone, and impact crushers; vibrating feeders; inclined and horizontal screens; various crushing plants; digital crusher controllers; aggregate and ore processing equipment; mobile screening plants; screen structures; vibrating screens; stationary rockbreaker systems; articulated production and utility vehicles; hydraulic breakers; compactors; demolition attachments; and bulk material handling and minerals processing equipment primarily for the aggregate, metallic mining, and recycling market s. The company?s Mobile Asphalt Paving Group segment provides asphalt pavers, asphalt material transfer vehicles, milling machines, and asphalt reclaiming and soil stabilizing machinery; asphalt paver screeds; windrow pickup machines; asphalt rollers and screeds primarily for road construction markets; and dirt and asphalt compaction equipment. Its Underground Group segment produces heavy-duty trenchers, compact horizontal directional drills, high pressure diesel powered pump trailers; maxi drills, auger boring machines, and down-hole tooling for these units; and vertical drills, water well drills, oil and gas drilling rigs, material handling trailers, and tools for the oil and gas, geothermal, and water well industries. The company also offers whole-tree pulpwood chippers, biomass chippers, horizontal grinders, and blower trucks. Astec Industries, Inc. sells its products through sales agents, distributors, and dealers. The company was founded in 1972 and is based in Chatta nooga, Tennessee.
Advisors' Opinion:- [By James E. Brumley]
What do Prospect Capital Corporation (NASDAQ:PSEC), Astec Industries, Inc. (NASDAQ:ASTE), and First Financial Corp. (NASDAQ:THFF) have in common? Not much, on the surface. In fact, were it not for something very specific to one particular person (me), they'd have nothing in common at all. This week though, THFF, ASTE, and PSEC all have at least one thing in common, and that's the fact that they're all going into my mental/hypothetical portfolio.
- [By GURUFOCUS]
John Maynard Keyes once opined: ��uccessful Investing is anticipating the anticipation of others.��That notion applies in spades when it comes to theme investing. Typically, a stock moves upwards long before its improvement in earnings comes to fruition. Warren Buffett colorfully observed: ��f you wait for the robins, spring will be over.��Should an investor wait for an earnings confirmation to validate his/her theory, then the time to invest will have already passed. I will end today�� discussion by profiling two successful investments I made in high quality cyclical companies during the period of the mid-2000s. The companies are: Maverick Tube (formerly MVK) and Astec (ASTE).
Top Managed Healthcare Stocks To Buy Right Now: AWG International Water Corp (AWGI)
AWG International Water Corporation, formerly MIPSolutions, Inc., incorporated on December 19, 2005, is a development-stage company. The principal business of the Company is the development of Molecularly Imprinted Polymers (MIPs) for various commercial applications, including the removal of targeted molecules from water.
The Company had a license agreement with The Johns Hopkins University Applied Physics Laboratory (JHU/APL). As of December 31, 2009, the Company was developing applications for the removal of arsenic from drinking water and for the extraction of precious metals from various mining operations.
Advisors' Opinion:- [By John Udovich]
Small cap OTC drinking water stocks Glacier Water Services, Inc (OTCMKTS: GWSV), AWG International Water Corp (OTCBB: AWGI) and Alkaline Water Company Inc (OTCBB: WTER) all offer a product that many consumer, investors and traders alike might take for granted, but everyone needs to have. However, you can build a better mouse trap when it comes to drinking water or at least that what these three small caps are attempting to do with their own unique strategies:
Top Managed Healthcare Stocks To Buy Right Now: Ishares Msci Singapore Ews (EWS)
iShares MSCI Singapore Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Singaporean market, as measured by the MSCI Singapore Index (the Index).
The Index seeks to measure the performance of the Singaporean equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. The Fund invests in a representative sample of securities in the Index, which has a similar investment profile as the Index. iShares MSCI Singapore Index Fund's investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Doug Fabian]
The country seems to have been boosted by an unexpected rise in manufacturing and gains in the service sector. One way to invest in Singapore is through the iShares MSCI Singapore ETF (EWS).
Top Managed Healthcare Stocks To Buy Right Now: Oshkosh Truck Corporation(OSK)
Oshkosh Corporation designs, manufactures, and markets a range of specialty vehicles, and vehicle bodies worldwide. Its Defense segment manufactures severe-duty, heavy, and medium-payload tactical trucks for the Department of Defense, including hauling tanks, missile systems, ammunition, fuel, and troops and cargo for combat units. The company?s Access Equipment segment offers aerial work platforms and telehandlers used in a range of construction, agricultural, industrial, institutional, and general maintenance applications. This segment also manufactures towing and recovery equipment and related parts; and leases equipments for short-term to rental companies. The company?s Fire and Emergency segment provides custom and commercial fire apparatus, and emergency vehicles, including pumpers, aerial and ladder trucks, tankers, rescue vehicles, wildland rough terrain response vehicles, mobile command and control centers, bomb squad vehicles, hazardous materials control vehicl es, and other emergency response vehicles. This segment also offers snow removal vehicles in airports; custom ambulances for private and public transporters, and fire departments; mobile medical trailers for medical centers and service providers; mobile command and control centers and simulation units; and vehicles for broadcasters, TV stations, broadcast production, and radio stations. Oshkosh Corporation?s Commercial segment manufactures refuse collection vehicles for the waste services industry; front and rear discharge concrete mixers, and portable and stationary concrete batch plants for the concrete ready-mix industry; and field service vehicles and truck-mounted cranes for the construction, equipment dealer, building supply, utility, tire service, and mining industries. The company was formerly known as Oshkosh Truck Corporation and changed its name to Oshkosh Corporation in February 2008. Oshkosh Corporation was founded in 1917 and is based in Oshkosh, Wisconsin.
Advisors' Opinion:- [By Ben Levisohn]
Stocks have battled back to little changed after falling this morning, as stocks like World Wrestling Entertainment (WWE) and Oshkosh (OSK) make big moves.
- [By gurujx]
Oshkosh Corporation (OSK): Exec. VP and CFO David M. Sagehorn Sold 141,005 Shares
Exec. VP and CFO David M. Sagehorn sold 141,005 shares of OSK stock on 11/18/2013 at the average price of $50.36. David M. Sagehorn owns at least 69,667 shares after this. The price of the stock has decreased by 6.29% since.
Top Managed Healthcare Stocks To Buy Right Now: Horizon Pharma Inc (HZNP)
Horizon Pharma, Inc. (Horizon), incorporated on March 23, 2010, is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501), a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company�� other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company�� distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation. On April 1, 2010, Horizon effected a recapitalization and acquisition pursuant to which Horizon Pharma, Inc. became a holding company, that operates through its wholly owned subsidiaries, Horizon Pharma USA, Inc. (formerly Horizon Therapeutics, Inc.) and Horizon Pharma AG (formerly Nitec Pharma AG (Nitec)).
DUEXIS
DUEXIS is a combination of 800 milligram ibuprofen and 26.6 milligram famotidine in a single pill and is indicated for the relief of signs and symptoms of rheumatoid arthritis (RA), and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal (GI), ulcers in patients who are taking ibuprofen for those indications. The Company has completed two Phase III clinical trials in a total of over 1,500 patients with mild to moderate pain or arthritis that demonstrated a significant reduction in the incidence of non-steroidal anti-inflammatory drugs (NSAID)-induced upper GI ulcers when treated with DUEXIS versus ibuprofen alone.
LODOTRA
LODOTRA is a programmed release formulation of low-dose prednisone, a well-established drug use! d to inhibit the production of various pro-inflammatory cytokines, which are proteins associated with joint inflammation in RA. LODOTRA has received regulatory approval in Europe for the treatment of moderate to severe, active RA in adults when accompanied by morning stiffness. As of December 31, 2010, the Company had completed two pivotal Phase III clinical trials of LODOTRA in a total of over 600 patients with RA. The first pivotal Phase III trial supported the approval of LODOTRA in Europe in March 2009, where it is approved for marketing in 14 European countries. LODOTRA achieved significant results and met the primary endpoint in each of the two pivotal Phase III clinical trials. Its LODOTRA product was developed and is owned by Horizon Pharma AG. As of December 31, 2010, the Company markets LODOTRA in Europe through three separate agreements. Pursuant to two separate agreements, it granted Merck Serono GmbH and Merck GesmbH, an affiliate of Merck Serono, the rights to distribute and market LODOTRA in each of Germany and Austria, respectively, and pursuant to the third agreement, it granted Mundipharma rights to distribute and market LODOTRA in the rest of Europe. The Company also has a manufacturing and supply agreement with Jagotec AG under which Jagotec or its affiliates manufacture and supply LODOTRA to the Company as bulk tablets.
The Company competes with Pfizer Inc., Pozen Inc., Abbott Laboratories and Amgen Inc.
Advisors' Opinion:- [By Jake L'Ecuyer]
Top losers in the sector included Horizon Pharma (NASDAQ: HZNP), off 9.5 percent, and Anacor Pharmaceuticals (NASDAQ: ANAC), down 8.2 percent.
Top Headline
The Greenbrier Companies (NYSE: GBX) reported a 13% gain in its fiscal second-quarter earnings. Greenbrier's quarterly profit surged to $15.6 million, or $0.50 per share, versus a year-ago profit of $13.8 million, or $0.45 per share. Excluding one-time items, it earned $0.51 per share. Its revenue climbed 88% to $502.2 million. However, analysts were expecting earnings of $0.60 per share on revenue of $508.69 million. - [By Jake L'Ecuyer]
Top losers in the sector included Horizon Pharma (NASDAQ: HZNP), off 9.5 percent, and Anacor Pharmaceuticals (NASDAQ: ANAC), down 8.2 percent.
Top Headline
The Greenbrier Companies (NYSE: GBX) reported a 13% gain in its fiscal second-quarter earnings. Greenbrier's quarterly profit surged to $15.6 million, or $0.50 per share, versus a year-ago profit of $13.8 million, or $0.45 per share. Excluding one-time items, it earned $0.51 per share. Its revenue climbed 88% to $502.2 million. However, analysts were expecting earnings of $0.60 per share on revenue of $508.69 million.
Top Managed Healthcare Stocks To Buy Right Now: Pacific Biosciences of California Inc.(PACB)
Pacific Biosciences of California, Inc., a development stage company, develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a technology platform that enables single molecule, real-time (SMRT) for the detection of biological processes. It primarily focuses on the deoxyribonucleic acid sequencing market. The company?s product includes the PacBio RS, a sequencing platform, which consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits. The company?s customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.
Advisors' Opinion:- [By Alex Planes]
However, Fool biotech expert Brian Orelli points out one big caveat: Once sequencing companies make these tests accessible, margins may collapse beyond the ability of volume sales to make up the difference. At least Illumina (and Life Tech) are in the driver's seat on margins, as it's unlikely that lesser-funded sequencing competitors Affymetrix (NASDAQ: AFFX ) and Pacific Biosciences (NASDAQ: PACB ) can muster the resources to push out sequencing at cost-effective scale before their peers.
No comments:
Post a Comment